Death due to COVID-19 in a patient with diabetes, epilepsy, and gout comorbidities
| Autor: | Farima Kahe, Pooya Farhangnia, Kaveh Momenzadeh, Amir Reza Safdarian, Nima Rezaei |
|---|---|
| Rok vydání: | 2022 |
| Předmět: |
Medicine (General)
Pediatrics Poor prognosis medicine.medical_specialty Gout Coronavirus disease 2019 (COVID-19) coronavirus Case Report SARS-COV-2 030204 cardiovascular system & hematology comorbidities law.invention 03 medical and health sciences Epilepsy R5-920 0302 clinical medicine COVID‐19 law Diabetes mellitus medicine Effective treatment In patient Intensive care medicine Past medical history business.industry Incidence (epidemiology) Diabetes COVID-19 General Medicine medicine.disease Intensive care unit comorbidity 030220 oncology & carcinogenesis Medicine business |
| Zdroj: | Clinical Case Reports Clinical Case Reports, Vol 9, Iss 1, Pp 461-464 (2021) |
| DOI: | 10.6084/m9.figshare.19323008.v1 |
| Popis: | There is evidence of increased incidence, rapid progression, and poor prognosis of COVID‐19 in patients with underlying comorbidities such as diabetes and epilepsy. Developing effective treatment regimens for COVID‐19 patients with multiple comorbidities is crucial, as patients' past medical history is an essential contributor to possible organ injuries in COVID‐19 patients. Herein, we report a confirmed case of COVID‐19 patient with a history of multiple underlying diseases, including diabetes, epilepsy, and gout. The patient developed multiple organ failure and died a week after intensive care unit (ICU) admission. Multiple organ failure is the most common cause of death in COVID‐19 patients. Developing effective treatment regimens for COVID‐19 patients with multiple comorbidities—especially diabetes and epilepsy—is crucial, as patients' past medical history is an essential contributor to possible organ injuries in COVID‐19 patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|